Treatment Selection in Ulcerative Colitis: Optimizing Outcomes through Patient-Centered Decision Making
Podcast 4: Patient-Centered Treatment Selection in UC

Questions marked with a * are required
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Date of  Participation
A 28-year-old male with a 4-year history of left-sided ulcerative colitis was treated with prednisone taper and azathioprine at diagnosis, but at 6 months had recurrent flare and initiated infliximab. He achieved and maintained clinical and endoscopic remission for 5 years on infliximab but has now returned to his gastroenterologist with recurrent flare symptoms including frequent loose, bloody stools, bowel urgency, and occasional fecal incontinence. He has expressed his preference for an orally dosed medication as he has a fear of needles. Given the patient’s goals and preferences which of the following treatment options would be most appropriate?
In the context of patient-centered decision making for therapy selection in ulcerative colitis, which of the following factors is considered the most important?
Powered by QuestionPro